Pennsylvania firm launches Zika vaccine trial in Puerto Rico
A Pennsylvania drug company announced Monday that it has launched a clinical trial of an experimental Zika vaccine in Puerto Rico, the part of the U.S. hardest hit by the mosquito-borne virus.
View ArticlePotential new treatment for cocaine addiction
A team of researchers led by Cardiff University has discovered a promising new drug treatment for cocaine addiction.
View ArticleFDA Oks first muscular dystrophy drug; awaits proof it works
Federal regulators on Monday granted tentative approval to the first drug for muscular dystrophy, following an intense public campaign from patients and doctors who pushed for the largely unproven...
View ArticleConsuming fewer calories reduces the risk of abdominal aortic aneurysm
Mice placed on a low-calorie diet are less likely to develop abdominal aortic aneurysms, according to a new study in The Journal of Experimental Medicine. The paper, "Calorie restriction protects...
View ArticleStudy finds new approach to block binge eating
A new therapeutic target for the treatment of compulsive binge eating has been identified by researchers at Boston University School of Medicine (BUSM).
View ArticleBe your own control: Cancer sequencing differs based on genetic background of...
When University of Colorado Cancer Center researcher, Jing Hong Wang, MD, PhD, found more than 1,000 genetic translocations in her mouse model of B cell lymphoma, she assumed her lab had made a...
View ArticleInjections might help prevent genital herpes transmission for months: study
(HealthDay)—Three injections of a therapeutic vaccine may control genital herpes as effectively as daily pills for at least a year, a new study suggests.
View ArticleResearchers propose noninvasive method to detect bone marrow cancer
For the first time, researchers have shown that using Magnetic Resonance Imaging (MRI) can effectively identify bone marrow cancer (myelofibrosis) in an experimental model.
View ArticleS.Africa launches major new trial of AIDS vaccine
South Africa on Wednesday launched a major clinical trial of an experimental vaccine against the AIDS virus, which scientists hope could be the "final nail in the coffin" for the disease.
View ArticleAfter gene therapy, hemophilia B patients maintain near-normal levels of...
Researchers are reporting the highest and most sustained levels to date of the essential blood-clotting factor IX in patients with the inherited bleeding disorder hemophilia B. After receiving a single...
View ArticleStanford patient is first infant to receive lifesaving drug for...
In 2013, Zoe Harting became the first baby in the world to receive an experimental drug that her doctors hoped would save the lives of thousands of infants like her.
View ArticleStudy results suggest improving posture may help reduce depression
(Medical Xpress)—A team of researchers at the University of Auckland has found evidence that suggests people who are depressed can improve their outlook simply by modifying their posture while sitting....
View ArticleEndurance training may have a protective effect on the heart
Findings published in Experimental Physiology suggest that exercise could be just as important for your heart heath as cholesterol and a healthy diet.
View ArticleResearchers find potential treatments for hemoglobinopathies
An article published in Experimental Biology and Medicine (Volume 242, Issue 3, February, 2017) identifies microRNAs (miRNAs) as key factors in some hemoglobinopathies, genetic disorders characterized...
View ArticleDietary supplement could improve heart health
Dietary intervention could benefit heart health in those with muscular dystrophy. That's according to new research published in Experimental Physiology. If these findings are confirmed in humans, it...
View ArticleAberrant synapse protein can lead to neurological and psychiatric disorders
'Timing is everything' in the transmission of signals between neurons in the brain. Most of the complex functions that humans are capable of performing would be severely impaired if their neurons were...
View ArticleMerck halts trial of once 'promising' Alzheimer's drug
US pharmaceutical giant Merck announced it is halting a clinical trial on a drug once touted as a promising treatment for Alzheimer's disease, saying studies show it does not work.
View ArticleNIH begins study of vaccine to protect against mosquito-borne diseases
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has launched a Phase 1 clinical trial to test an investigational vaccine intended to...
View ArticleConformity is not a universal indicator of intelligence in children, study says
Because innovation is part of the American culture, adults in the United States may be less likely to associate children's conformity with intelligence than adults from other populations, according to...
View ArticleWhy do we develop high blood pressure?
Abnormally high blood pressure, or hypertension, may be related to changes in brain activity and blood flow early in life. That's according to a study conducted on a rat model of high blood pressure,...
View Article